Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000908662-07-000003
Filing Date
2007-01-03
Accepted
2007-01-03 16:45:39
Documents
1
Period of Report
2006-12-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3706
  Complete submission text file 0000908662-07-000003.txt   5660
Mailing Address 175 CROSSING BLVD FRAMINGHAM MA 01701
Business Address 175 CROSSING BLVD FRAMINGHAM MA 01701 508620-970
GTC BIOTHERAPEUTICS INC (Issuer) CIK: 0000904973 (see all company filings)

EIN.: 043186494 | State of Incorp.: MA | Fiscal Year End: 0101
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address GTC BIOTHERAPEUTICS, INC. 175 CROSSING BOULEVARD FRAMINGHAM MA 01702
Business Address C/O GTC BIOTHERAPEUTICS, INC. 175 CROSSING BOULEVARD FRAMINGHAM MA 01702 5086209700
GERAGHTY JAMES A (Reporting) CIK: 0001239746 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21794 | Film No.: 07505299